CASE REPORT
===========

A 63-year-old male visited the hospital for chest pain. A simple chest radiologic examination suggested an anterior mediastinum tumor. Other than the chest pain, the patient did not show myasthenia gravis or any other notable symptoms on physical examination. A chest computed tomography (CT) showed a 6.8 cm tumor at the anterior mediastinum ([Fig. 1](#F1){ref-type="fig"}). The tumor seemed to cover the left innominate vein and invade the thoracic wall. This tumor had invaded the sternum, left side of the parasternal area, ribs, and intercostal muscles. Based on the positron emission tomography\--CT results, hypermetabolic uptake lesions were noted at the main mass and lymph nodes of the 3rd and 4th left costal bones and paratracheal area. Accordingly, preoperative percutaneous needle biopsy was executed for the main mass, and the result came out as thymic carcinoma with the possibility of squamous cell carcinoma.

Five cycles of neoadjuvant chemotherapy (paclitaxel+cisplatin) were followed. After chemotherapy for three months, the tumor size seemed to have increased, but did not show any other metastasis according to the other test results. Considering the patient and disease status, surgical treatment was planned.

After general anesthesia, a single-lumen endotracheal tube was inserted and the operation proceeded in the supine position. After a median skin incision, the mass invading the chest wall was observed. Thus, undermining of both subcutaneous layers and muscle layers was performed in order to determine the invasion range. In addition, extensive resection procuring the tumor margin was performed at the sternal body and 2nd through 5th intercostal rib cartilages using an oscillating saw and rib cutter ([Fig. 2](#F2){ref-type="fig"}). The tumor not only had invaded the sternum and both chest walls, but had also invaded the left jugular vein and the brachiocephalic vein, which were shrunken due to the tumor and had adhered to the left upper lobe. Hence, after saving and detachment of the left phrenic nerve, division at the superior vena cava-innominate vein junction and left jugular vein proximal area was performed by vascular endo-GIA. Despite the obstruction of the innominate vein and left jugular vein, symptoms such as left arm and facial swelling did not appear preoperatively. Therefore, only vascular resection without reconstruction was done, and no such symptoms were noted postoperatively. Tumor invasion to both lungs was also found. Therefore, both pleurae were opened, and wedge resections of the right and left upper lobes were performed using GIA staplers. Since the tumor was also abutting the aortic arch, the parietal pericardium was opened and the tumor was cautiously detached and removed from the aortic wall ([Fig. 3](#F3){ref-type="fig"}).

The sternum and chest wall defect was wide and chest wall reconstruction using a Permacol patch (20×15 cm) was planned. The margin of the defect was calculated as stated in [Fig. 2](#F2){ref-type="fig"}, and was tailored based on the shape of the defect. Using steel wire for the upper margin, suture of the manubrium and a tailored patch were performed. The tailored patch was anchored at the lateral margins of the bilateral ribs and the lower margin with multiple intermittent sutures using 1/0 polypropylene. Finally, the chest wall reconstruction was completed ([Fig. 4](#F4){ref-type="fig"}).

Postoperative pathological examination confirmed that the tumor was thymic carcinoma (large-cell neuroendocrine carcinoma). Despite a normal appearance on intraoperative gross examination, the resection margins of the superior, medial, and lateral areas showed tumor involvement. In addition, metastasis to one lymph node (LN11) was confirmed.

The patient was transferred to the intensive care unit after the surgery, was extubated after 20 hours, and was transferred to the general ward on day 2 postoperatively. The mediastinal chest tube was removed on postoperative day 5, the pericardial Hemovac drain was removed on day 10 postoperatively, and the patient was discharged on postoperative day 19 without showing any other complications.

Considering R1 resection at the surgical margins, postoperative chemoradiation (chemotherapy, low-dose cisplatin: 7 cycles, radiotherapy, total 6,300 cGy/34F) was applied beginning from day 29 after surgery. Based on chest CT results taken 6 months after surgery, no signs of tumor relapse were observed and the patient did not show any abnormal signs or symptoms ([Fig. 5](#F5){ref-type="fig"}).

DISCUSSION
==========

Thymic carcinoma is a rare type of cancer among thymic gland cancers, and chest pain, chest discomfort, cough, and sputum are some of the well-known symptoms. Thymic carcinoma often has progressed locally or metastasized remotely when observed. As a result, complete removal is often impossible and remote metastasis or local relapse is frequent, which results in a poor prognosis \[[@B1],[@B2]\]. Complete resection is known to be the most effective treatment for thymic carcinoma. It is also reported to be the most important factor for determining the patient\'s prognosis. Since single treatment methods such as anticancer chemotherapy or radiotherapy have their limits, multimodality treatment is suggested.

In this case, sternal invasion was verified and reconstruction was necessary for the large defect after wide resection. The key aspects in chest wall reconstruction are protection of the internal organs, conservation of the thorax mobility range, and closure of the pleural cavity. Flail chest, paradoxical movement, pneumonia, pleural effusion, thoracic instability, infection, hematoma, and seroma are some of the most well-known complications \[[@B3]\].

Soft tissue reconstruction using a musculocutaneous flap was frequently used in the past for chest wall reconstruction of small defects. However, due to its limitation in repairable size and movement range, it has not been found to be suitable for large defect reconstruction, and also had a high risk of wound dehiscence when vascularity worsened. Starting from the 1980s, prosthetic materials were used as an alternative for chest wall reconstruction. However, side effects such as dislocation, infection, fistula, dense scarring, erosion, cracking, and bleeding are still a concern, and they cannot be used when infection is in progress.

Thus, bioprosthetic patches with a low infection risk are now being used. AlloDerm (LifeCell Co., Branchburg, NJ, USA), Dermamatrix (Musculoskeletal Transplant Foundation, Edison, NJ, USA), Surgisis (Cook Surgical, Bloomington, IN, USA), and Permacol (Tissue Sciences Laboratories plc, Aldershot, UK) are some of the commonly used biologic meshes. AlloDerm and Dermamatrix are freeze-dried human dermal tissue without inflammatory substances and cells, which show less rejection and shortened skin tissue regeneration time, and prevent burn scar contracture of the joint. However, as a tissue obtained from a corpse, it is highly probable that damaged elastin is included. As a result, the infection risk is also high as well as the risk of being absorbed or adhered after transplant. Surgisis, on the other hand, is a tissue obtained from pig intestinal submucosal collagen, which does not include elastin, while being strong due to collagen and is useful for transplanting tissues with high elasticity \[[@B4]\].

Permacol is an acellular sheet of porcine dermal collagen and its constituent elastin fibers are said to maintain their original three dimensional forms with the collagen fibers cross-linked using diisocyanate. This cross-linking with lysine and hydroxylysine residues within the collagen fibers of Permacol imparts a higher resistance to collagenases, a property which may account for its long-term durability \[[@B5]\].

In chest wall reconstruction after wide chest wall resection, the use of a musculocutaneous flap or prosthetic materials is inevitable for maintaining thoracic movement and closed pleural cavity. In this case, a successful chest wall reconstruction using a biological mesh named Permacol was verified. Considering its low infection risk and high strength and durability, it can be applied to large chest wall defects. Accordingly, it is thought to be applicable to the reconstruction of other chest or abdominal wall defect reconstruction.
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![Chest computed tomography shows an anterior mediastinal mass invading chest wall and costal cartilage, abutting the aortic arch and parietal pericardium.](kjtcs-46-312-g001){#F1}

![Upper 2/3 of sternal body with lower half of manubrium and 2nd through 5th intercostal rib cartilages at both sides were resected.](kjtcs-46-312-g002){#F2}

![Specimen consists of sternum, rib, sternal mass and wedge resected lung.](kjtcs-46-312-g003){#F3}

![Permacol sewn into place with 1-0 polypropylene intermittent sutures.](kjtcs-46-312-g004){#F4}

![Therefore only vascular resection without reconstruction was done and no such symptoms were noted postoperatively.](kjtcs-46-312-g005){#F5}
